Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 13 Observational 1

Sponsor

Conditions

Pain 2 Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Neutropenia 1 Neuralgia 1 Neoplasms 1 Multiple Pulmonary Nodules 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Infections 1 Hypokalemia 1 Hypertension 1 Hyperaldosteronism 1 Herpes Simplex 1 Hemophilia A 1

Interventions

Methadone 2 oxycodone naloxone combination 1 Tapentadol 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Pharmacogenomic Testing 1 Oxycodone 1 Morphine 1 Interviews as Topic 1 Hydromorphone 1 Focus Groups 1 Fentanyl 1 Diagnostic Tests, Routine 1 Buprenorphine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Cancer Pain × Oxycodone × Clear all

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡